Trademarkia Logo

Australia

AU$
NUGALVIQ
Protected: Registered/protected

Last updated on 23 Nov 2021

Owner Info

Applied Therapeutics, Inc.

545 Fifth Avenue, Suite 1400

New York NY 10017, UNITED STATES OF AMERICA

Serial Number

2207273 filed on 29 Jun 2021

Correspondent

Anna Kurian Shaw Hogan Lovells US LLP

555 13th Street NW,

Washington DC 20004,

UNITED STATES OF AMERICA

NUGALVIQ

Classification Information


Class [005]
Pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose Read More

Mark Details


Serial Number

2207273

Registered On

29 Jun 2021

Renewal On

29 Jun 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

30 Dec 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
23rd Nov 2021International Registration in Australia Protected correspondence sent
22nd Nov 2021IP Right Registration Published
22nd Nov 2021Status change to Registered/Protected
14th Sept 2021Application Accepted correspondence sent
13th Sept 2021IP Right has been Examined
13th Sept 2021IP Right Acceptance Published
13th Sept 2021Status change to Accepted
8th Sept 2021Awaiting examination
8th Sept 2021Examination expedited
2th Sept 2021IP Right Filed Published